AIRLINK 196.50 Increased By ▲ 2.94 (1.52%)
BOP 10.25 Increased By ▲ 0.30 (3.02%)
CNERGY 7.88 Decreased By ▼ -0.05 (-0.63%)
FCCL 39.80 Decreased By ▼ -0.85 (-2.09%)
FFL 17.09 Increased By ▲ 0.23 (1.36%)
FLYNG 27.12 Decreased By ▼ -0.63 (-2.27%)
HUBC 133.95 Increased By ▲ 1.37 (1.03%)
HUMNL 14.10 Increased By ▲ 0.21 (1.51%)
KEL 4.78 Increased By ▲ 0.18 (3.91%)
KOSM 6.64 Increased By ▲ 0.02 (0.3%)
MLCF 47.18 Decreased By ▼ -0.42 (-0.88%)
OGDC 214.79 Increased By ▲ 0.88 (0.41%)
PACE 6.96 Increased By ▲ 0.03 (0.43%)
PAEL 42.00 Increased By ▲ 0.76 (1.84%)
PIAHCLA 17.15 No Change ▼ 0.00 (0%)
PIBTL 8.50 Increased By ▲ 0.09 (1.07%)
POWER 9.60 Decreased By ▼ -0.04 (-0.41%)
PPL 183.96 Increased By ▲ 1.61 (0.88%)
PRL 42.90 Increased By ▲ 0.94 (2.24%)
PTC 25.15 Increased By ▲ 0.25 (1%)
SEARL 109.80 Increased By ▲ 2.96 (2.77%)
SILK 1.00 Increased By ▲ 0.01 (1.01%)
SSGC 44.11 Increased By ▲ 4.01 (10%)
SYM 17.86 Increased By ▲ 0.39 (2.23%)
TELE 8.96 Increased By ▲ 0.12 (1.36%)
TPLP 13.06 Increased By ▲ 0.31 (2.43%)
TRG 67.60 Increased By ▲ 0.65 (0.97%)
WAVESAPP 11.68 Increased By ▲ 0.35 (3.09%)
WTL 1.83 Increased By ▲ 0.04 (2.23%)
YOUW 3.97 Decreased By ▼ -0.10 (-2.46%)
BR100 12,249 Increased By 204.5 (1.7%)
BR30 36,933 Increased By 352.6 (0.96%)
KSE100 115,663 Increased By 1625.1 (1.43%)
KSE30 36,398 Increased By 603.9 (1.69%)

Pakistan Pharmaceutical Manufacturers' Association (PPMA) has warned to increase prices of medicines manufactured in the country by 40 percent in a month, if the government takes no relief measure to support the local drugs' producers in view of massive rupee devaluation and other related pressing fiscal factors.
Speaking at a press conference held at local hotel here, Zahid Saeed, Central Chairman PPMA said some 250 medicines have virtually vanished from the Pharma market as their manufacturers did find it simply unfeasible to keep producing them given the irrational pricing of the government for these drugs.
He said that 40 per cent increase in prices of locally produced medicines would be a highly undesirable step for pharmaceutical manufacturers of the country as such a decision would only be taken to keep the industry afloat only for the sake of patients' needs.
"We know very much what could be the serious repercussions of our unilateral decision but this will be like the last resort for us to keep our businesses viable and functioning as otherwise ailing citizenry of this country would be the ultimate sufferers," he said. He said that manufacturing cost of the medicines in the country had been lately increased up to 60 per cent given the record devaluation of rupee and increase in duties and taxes on the industry.
He said that federal government was still reluctant to notify the new prices of a number of medicines as recommended by the Drug Pricing Committee (DPC) over a year ago. He said that it was high time for the government to notify new prices of medicines as per the recommendations of the DPC as any further delay to this effect would compel the Pharma industry to take a unilateral decision.
Zahid demanded that whatever drug pricing mechanism was adopted by the government, it should include the factor of fluctuation of the value of the local currency to keep the Pharma industry viable for the continuance of its production.
Former chairman PPMA Dr Kaiser Waheed said that government had no regard towards the cause of keeping the manufacturers of the medicines a viable industry. Therefore, the government even now insists on further slashing the prices of locally produced drugs as it should keep in mind that the medicines' prices in Pakistan are one of the lowest in the region as there is no valid cause to further bring them down," he said.
Both PPMA leaders demanded Prime Minister, Federal minister, and secretary for Ministry of National Health Services, Regulation, & Coordination; and Drug Regulatory Authority of Pakistan to immediately take corrective measures in order to provide relief to the local Pharma industry.

Copyright Business Recorder, 2018

Comments

Comments are closed.